Abstract:Significance: The choroid plexus (ChP) epithelial network displays diverse dynamics, including propagating calcium waves and individuated fluctuations in single cells. These rapid events underscore the possibility that ChP dynamics may reflect behaviorally relevant and clinically important changes in information processing and signaling. Optogenetic and chemogenetic tools provide spatiotemporally precise and sustained approaches for testing such dynamics in vivo. Here, we describe the feasibility of a novel combined opto- and chemogenetic tool, BioLuminescent-OptoGenetics (BL-OG), for the ChP in vivo. In the "LuMinOpsin" (LMO) BL-OG strategy, a luciferase is tethered to an adjacent optogenetic element. This molecule allows chemogenetic activation when the opsin is driven by light produced through luciferase binding a small molecule (luciferin) or by conventional optogenetic light sources and BL-OG report of activation through light production. Aim: To test the viability of BL-OG/LMO for ChP control. Approach: Using transgenic and Cre-directed targeting to the ChP, we expressed LMO3 (a Gaussia luciferase-VChR1 fusion), a highly effective construct in neural systems. In mice expressing LMO3 in ChP, we directly imaged BL light production following multiple routes of coelenterazine (CTZ: luciferin) administration using an implanted cannula system. We also used home-cage videography with Deep LabCut analysis to test for any impact of repeated CTZ administration on basic health and behavioral indices. Results: Multiple routes of CTZ administration drove BL photon production, including intracerebroventricular, intravenous, and intraperitoneal injection. Intravenous administration resulted in fast "flash" kinetics that diminished in seconds to minutes, and intraperitoneal administration resulted in slow rising activity that sustained hours. Mice showed no consistent impact of 1 week of intraperitoneal CTZ administration on weight, drinking, motor behavior, or sleep/wake cycles. Conclusions: BL-OG/LMO provides unique advantages for testing the role of ChP dynamics in biological processes.

Efficient opto- and chemogenetic control in a single molecule driven by FRET-modified bioluminescence

BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo

Engineering luminopsins with improved coupling efficiencies

Novel luciferase–opsin combinations for improved luminopsins

Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation

Strength of Activation and Temporal Dynamics of BioLuminescent-Optogenetics in Response to Systemic Injections of the Luciferin

Optogenetic Engineering to Probe the Molecular Choreography of STIM1-mediated Cell Signaling

Optogenetic control of cell function using engineered photoreceptors

Bioluminescence as a functional tool for visualizing and controlling neuronal activity in vivo

Guiding lights: recent developments in optogenetic control of biochemical signals

A bistable inhibitory optoGPCR for multiplexed optogenetic control of neural circuits

A synthetic BRET-based optogenetic device for pulsatile transgene expression enabling glucose homeostasis in mice

An Ultra-Sensitive Step-Function Opsin for Minimally Invasive Optogenetic Stimulation in Mice and Macaques.

Optogenetics for light control of biological systems

Light control of G protein signaling pathways by a novel photopigment

An optimized bioluminescent substrate for non-invasive imaging in the brain

optogenetics using a Utah Optrode Array with enhanced light output and spatial selectivity

OPTO-BLUE: An Integrated Bidirectional Optogenetic Lentiviral Platform for Controlled Light-Induced Gene Expression

Colocalized, bidirectional optogenetic modulations in freely behaving mice with a wireless dual-color optoelectronic probe

Photoactivation of LOV domains with chemiluminescence